ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma

Satoshi Yanagida1, Kenzui Taniue, Hironobu Sugimasa

  • 1Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.

Scientific Reports
|February 20, 2013
PubMed

Insights

Antisense RNA ASBEL promotes ovarian cancer by blocking ANA/BTG3 protein transport. Reducing ASBEL inhibits tumor growth, revealing a new mechanism in cancer development.

Area of Science:

  • Molecular biology
  • Genomics
  • Cancer research

Background:

  • Antisense non-coding RNAs regulate gene expression, but their mechanisms and disease links are unclear.
  • ANA/BTG3 protein, an antiproliferative factor, is downregulated in cancers.
  • Ovarian clear cell carcinoma (OCCC) is a significant gynecological malignancy.

Purpose of the Study:

  • To investigate the role of the ANA/BTG3 antisense transcript (ASBEL) in OCCC.
  • To elucidate the mechanism by which ASBEL affects ANA/BTG3 expression and function.
  • To determine ASBEL's contribution to cancer proliferation and tumorigenicity.

Main Methods:

  • Gene knockdown experiments (ASBEL and ANA/BTG3).
  • Analysis of protein and mRNA levels.
  • Cellular localization studies (nuclear and cytoplasmic transport).
  • Assessment of cell proliferation and tumorigenicity.

Main Results:

  • ASBEL negatively regulates ANA/BTG3 protein levels, not mRNA.
  • ASBEL is essential for OCCC proliferation and tumorigenicity.
  • ASBEL forms nuclear duplexes with ANA/BTG3 mRNA, inhibiting its cytoplasmic transport.
  • Knockdown of ANA/BTG3 rescues growth inhibition caused by ASBEL knockdown.

Conclusions:

  • ASBEL promotes tumorigenesis by inhibiting ANA/BTG3 mRNA translation via suppressed cytoplasmic transport.
  • This study reveals a novel mechanism of antisense transcript function in cancer development.
  • Targeting ASBEL may offer a therapeutic strategy for OCCC.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...